Journal of the Japan Diabetes Society
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Volume 51, Issue 7
Displaying 1-10 of 10 articles from this issue
Original Article
  • Ken Tomotsune, Yoshiji Ogawa, Noriyuki Hasegawa, Takanori Kudou, Maki ...
    2008 Volume 51 Issue 7 Pages 587-591
    Published: 2008
    Released on J-STAGE: May 20, 2009
    JOURNAL FREE ACCESS
    We assesed the relationship between depression and diabetic control using the Self-Rating Questionnaire for Depression (SRQ-D) in 174 diabetic patients. The subjects were divided into 5 groups according to their HbA1c level. The groups with HbA1c values from 5.8% to 6.5% and from 6.5% to 7.0% showed significantly lower SRQ-D scores. Terfore, we defined the groups with HbA1c values from 5.8% to 7.0% as “moderately well controlled groups” and the remaining as “poorly controlled groups”. Furthermore, the sex, age, diabetes type, insulinuse, obesity and number of oral tablets consumed daily were also found to be related to the presence/absence of depression. Stepwise multiple regression analysis was performed using these 7 parameters, and diabetic control, sex, age, obesity and number of oral tablets consuned daily were found to be significant independent variables related to depression. In conclusion, it was revealed that sex, age, obesity, number of oral tablets consumed daily and diabetic control were related independently to the presence/absence of depression. It is, therefore, important to examine the patiens paying careful attention to the features described above.
    Download PDF (339K)
  • Hitoshi Ishii, Miyuki Furuya, Tadao Iburi, Keiko Yamagami, Rieko Ishib ...
    2008 Volume 51 Issue 7 Pages 593-600
    Published: 2008
    Released on J-STAGE: May 20, 2009
    JOURNAL FREE ACCESS
    We performed a study to develop a questionnaire to measure the impact of insulin treatment on the quality of life (QOL) of insulin-treated patients, focusing on the period from bedtime to early morning. The “Insulin Therapy Related QOL at Night (ITR-QOLN)” questionnaire consisted of 21 questions divided into 4 domains: anxiety before sleep (anxiety about nocturnal hypoglycemia before bedtime), disturbances during sleep (hypoglycemic disorder from bedtime to early morning), glycemic control before breakfast, and overall well-being. The test-retest reliability and internal consistency were high, based on Pearson's correlation coefficient and factor analysis. In relation to concurrent validity, a strong correlation was found between the scores on the ITR-QOLN and those on the well-being scale (W-BQ 12). We concluded that the ITR-QOLN questionnaire is valid measure of the nocturnal QOL in patients receiving insulin treatment.
    Download PDF (295K)
  • Hitoshi Ishii, Miyuki Furuya, Tadao Iburi, Keiko Yamagami, Rieko Ishib ...
    2008 Volume 51 Issue 7 Pages 601-608
    Published: 2008
    Released on J-STAGE: May 20, 2009
    JOURNAL FREE ACCESS
    We investigated the influence of insulin treatment on the patients' QOL and relationship of the QOL to diabetes treatment-related clinical parameters using the newly developed “Insulin Therapy Related QOL questionnaire at night” (ITR-QOLN). Type 1 diabetes patients showed lower QOL scores than that in type 2 diabetes patients. With regard to glycemic control, patients with lower HbA1c or lower mean fasting plasma glucose values before breakfast showed higher QOL scores. Further, higher QOL scores were seen in patients with lesser variations of the plasma glucose before breakfast or at bedtime. Although the QOL scores were low in patients with episodes of hypoglycemia, the scores were higher in patients who were confident of treating the hypoglycemia episodes by themselves. In conclusion, it was demonstrated that both achieving desirable blood glucose control and aiming at fewer hypoglycemia episodes are essential to achieve higher QOL in patients receiving insulin treatment.
    Download PDF (283K)
Case Report
Co-medical
feedback
Top